Maprotiline

Maprotiline is primarily used for treating major depressive disorder. Its unique profile allows it to be effective in patients who may not respond well to standard selective serotonin reuptake inhibitors (SSRIs) or other tricyclic antidepressants. Additionally, it has been investigated for potential anti-cancer properties against certain types of lymphoma and liver cancer.

Maprotiline exhibits significant biological activity as an antidepressant. Its mechanism primarily involves:

• Inhibition of norepinephrine reuptake: This action enhances norepinephrine levels in the brain, contributing to its antidepressant effects.
• Anticholinergic effects: While it has some anticholinergic properties, these are less pronounced compared to other tricyclic antidepressants like amitriptyline.
• Sedative effects: Maprotiline can induce sedation, making it suitable for treating patients with agitation or suicidal ideation.

Adverse effects may include dry mouth, constipation, and potential cardiovascular issues such as arrhythmias.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.